Enhancing mRNA vaccine production: Optimization of in vitro transcription for improved yield and purity
Biotechnology Progress · 2026
DOI: 10.1002/btpr.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2026. Verfasst von Kaixi Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Process Research and Development, Merck & Co., Inc, Rahway, New Jersey, USA. Hauptthemen laut MEDLINE: Transcription, Genetic, RNA, Messenger, mRNA Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Merck Sharp and Dohme, Merck Sharp and Dohme K.K..
Abstract (Originalsprache)
In vitro transcription (IVT) is a powerful method to generate RNA which not only facilitates RNA research but also plays a key role in the development and manufacture of RNA‐based vaccines. mRNA is produced via the IVT process with a DNA template that contains information for the target antigen. However, as many disease‐causing viruses mutate quickly and the cost of raw materials is high for the IVT reaction, there is a need for a system to develop a cost‐effective and efficient IVT process platform. In this paper, we showed how total nucleoside‐5′‐triphosphates (NTPs) input, Mg 2+ concentration and NTP preparation methods can influence IVT reaction yield and purity level of the final RNA constructs of different lengths and sequences. We propose an IVT design that will result in high RNA yield, high RNA integrity and low double‐stranded RNA (dsRNA) concentrations for multiple RNA sequences. The approach presented here could significantly contribute to the development of a cost‐effective, easy‐to‐adopt IVT process platform for RNA manufacturing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Process Research and Development, Merck & Co., Inc, Rahway, New Jersey, USA.
- Analytical Research and Development, Merck & Co., Inc, Rahway, New Jersey, USA.
- Eurofins PSS Insourcing Solutions, Lancaster, Pennsylvania, USA.
ORCID-Profile: Kaixi Zhao, Jessica Raffaele, Emily Wen
Förderung
- Merck Sharp and Dohme
- Merck Sharp and Dohme K.K.
Zitieren
APA
Zhao, K., Raffaele, J., Holland, D. A., Feibelman, K., Lengel, K., Shanter, J., & Wen, E. (2026). Enhancing mRNA vaccine production: Optimization of in vitro transcription for improved yield and purity. Biotechnology Progress. https://doi.org/10.1002/btpr.70109
Vancouver
Zhao K, Raffaele J, Holland DA, Feibelman K, Lengel K, Shanter J, et al. Enhancing mRNA vaccine production: Optimization of in vitro transcription for improved yield and purity. Biotechnology Progress. 2026. doi:10.1002/btpr.70109
BibTeX
@article{Zhao2026,
author = {Zhao, Kaixi and Raffaele, Jessica and Holland, David A and Feibelman, Kristen and Lengel, Kathleen and Shanter, Jon and Wen, Emily},
title = {Enhancing mRNA vaccine production: Optimization of in vitro transcription for improved yield and purity},
journal = {Biotechnology Progress},
year = {2026},
doi = {10.1002/btpr.70109}
}
EUVIMED